The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Hepatocellular carcinoma pathogenesis: from genes to environment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,642
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
The Liver: Biology and Pathobiology.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-690_3 · Cited by 1,590
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Tissue repair and stem cell renewal in carcinogenesis
Beachy, P. A., Karhadkar, S. S., & Berman, D. M. (2004) · Nature · doi:10.1038/nature03100 · Cited by 1,208
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Viral dynamics in hepatitis B virus infection.
Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4398 · Cited by 1,045
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“Along these lines, intra-tumoral immunocytes have been shown to enable the angiogenic switc”
BackgroundClassification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Unravelling hepatitis C virus replication from genome to function
Lindenbach, B. D., & Rice, C. M. (2005) · Nature · doi:10.1038/nature04077 · Cited by 820
Management of hepatitis B: 2000—Summary of a workshop
Lok, A. S., Heathcote, E. J., & Hoofnagle, J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.24839 · Cited by 776
Adaptive immune responses in acute and chronic hepatitis C virus infection
Bowen, D. G., & Walker, C. M. (2005) · Nature · doi:10.1038/nature04079 · Cited by 756
Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., & Merlino, G. T. (1990) · Cell · doi:10.1016/0092-8674(90)90076-q · Cited by 710
Wnt signaling in the intestinal epithelium: from endoderm to cancer
Gregorieff, A., & Clevers, H. (2005) · Genes & Development · doi:10.1101/gad.1295405 · Cited by 679
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
The role of hepatocytes and oval cells in liver regeneration and repopulation
Fausto, N., & Campbell, J. S. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00338-6 · Cited by 648
Evasion of intracellular host defence by hepatitis C virus
Gale, M., & Foy, E. M. (2005) · Nature · doi:10.1038/nature04078 · Cited by 633
MacSween, N. M. R. (1979) · Churchill Livingstone eBooks · Cited by 575
Foy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T., Lemon, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408707102 · Cited by 548
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517
Moriya, K., Nakagawa, K., Santa, T., Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Miyazawa, T., Ishibashi, K., Horie, T., et al. (2001) · PubMed · Cited by 515
Iizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
Kurz, D. J., Decary, S., Hong, Y., Trivier, E., Akhmedov, A., & Erusalimsky, J. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01097 · Cited by 499
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Ethanol, oxidative stress, and cytokine-induced liver cell injury
Hoek, J. B., & Pastorino, J. G. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00215-x · Cited by 478
Lee, J.-S., Chu, I.-S., Mikaelyan, A., Calvisi, D. F., Heo, J., Reddy, J. K., & Thorgeirsson, S. S. (2004) · Nature Genetics · doi:10.1038/ng1481 · Cited by 475
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Okuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
Hepatocellular Carcinoma: Epidemiology, Risk Factors, and Screening
Sherman, M. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871194 · Cited by 404
Zhu, A. X., Blaszkowsky, L. S., Ryan, D. P., Clark, J. W., Muzikansky, A., Horgan, K., Sheehan, S., Hale, K. E., Enzinger, P. C., Bhargava, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9130 · Cited by 388
Functional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Epidemiology of Hepatitis C Virus (HCV) Infection
Sy, T., & Jamal, M. M. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.41 · Cited by 361
Schiffer, E., Housset, C., Cacheux, W., Wendum, D., Desbois‐Mouthon, C., Rey, C., Clergue, F., Poupon, R., Barbu, V., & Rosmorduc, O. (2005) · Hepatology · doi:10.1002/hep.20538 · Cited by 340
Weiner, A., Erickson, A. L., Kansopon, J., Crawford, K., Muchmore, E., Hughes, A. L., Houghton, M., & Walker, C. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2755 · Cited by 334
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333
Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 331
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J.-H., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 330
Recent concepts in non‐alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01748.x · Cited by 324
Genetic mechanisms of hepatocarcinogenesis
Feitelson, M. A., Sun, B., Lale Satiroglu Tufan, N., Liu, J., Pan, J., & Lian, Z. (2002) · Oncogene · doi:10.1038/sj.onc.1205434 · Cited by 322
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
Ito, Y., Takeda, T., Sakon, M., Tsujimoto, M., Higashiyama, S., Noda, K., Miyoshi, E., Monden, M., & Matsuura, N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1580 · Cited by 321
Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112515399 · Cited by 317
Self-citationTahara, H., Nakanishi, T., Kitamoto, M., NAKASHIO, R., Shay, J. W., Tahara, E., Kajiyama, G., & Ide, T. (1995) · PubMed · Cited by 310
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Kew, M. C. (2003) · Liver International · doi:10.1111/j.1478-3231.2003.00869.x · Cited by 302
Peng, S., Chen, W. J., Lai, P., Jeng, Y., Sheu, J., & Hsu, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20279 · Cited by 295
Hsu, H.-C., Jeng, Y.-M., Mao, T.-L., Chu, J.-S., Lai, P.-L., & Peng, S.-Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64590-7 · Cited by 294
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., & Cerutti, P. (1994) · Science · doi:10.1126/science.8191284 · Cited by 282
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Shimoda, R., Nagashima, M., Sakamoto, M., Yamaguchi, N., Hirohashi, S., Yokota, J., & Kasai, H. (1994) · PubMed · Cited by 279
Wong, N., Lai, P., Lee, S.-W., Fan, S., Pang, E., Liew, C.-T., Sheng, Z., Lau, J. W.-Y., & Johnson, P. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65248-0 · Cited by 275
Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
Majumder, M., Ghosh, A. K., Steele, R., Ray, R., & Ray, R. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1401-1407.2001 · Cited by 255
Telomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246
Self-citationIncidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
Yu, D.-Y., Moon, H.-B., Son, J.-K., Jeong, S., Yu, S.-L., Yoon, H., Han, Y.-M., Lee, C.-S., Park, J.-S., Lee, C.-H., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80172-x · Cited by 242
Murakami, H., Sanderson, N. D., Nagy, P., Marino, P. A., Merlino, G. T., & Thorgeirsson, S. S. (1993) · PubMed · Cited by 239
Ferber, M. J., Montoya, D. P., Yu, C., Aderca, I., McGee, A., Thorland, E. C., Nagorney, D. M., Gostout, B. S., Burgart, L. J., Boix, L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206528 · Cited by 238
Galli, A., Svegliati‐Baroni, G., Ceni, E., Milani, S., Ridolfi, F., Salzano, R., Tarocchi, M., Grappone, C., Pellegrini, G., Benedetti, A., et al. (2005) · Hepatology · doi:10.1002/hep.20683 · Cited by 235
Unscrambling hepatitis C virus–host interactions
Chisari, F. V. (2005) · Nature · doi:10.1038/nature04076 · Cited by 224
Dumble, M. L., Croager, E. J., Yeoh, G. C. T., & Quail, E. A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.435 · Cited by 222
Edamoto, Y., Hara, A., Biernat, W., Terracciano, L., Cathomas, G., Riehle, H., Matsuda, M., Fujii, H., Scoazec, J., & Ohgaki, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11254 · Cited by 220
Cha, M.-Y., Kim, C.-M., Park, Y.-M., & Ryu, W.-S. (2004) · Hepatology · doi:10.1002/hep.20245 · Cited by 220
Kusano, N., Shiraishi, K., Kubo, K., Oga, A., Okita, K., & Sasaki, K. (1999) · Hepatology · doi:10.1002/hep.510290636 · Cited by 208
p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
Matsuda, Y., Ichida, T., Matsuzawa, J., Sugimura, K., & Asakura, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70137-x · Cited by 202
Farazi, P. A., Glickman, J. N., Jiang, S., Yu, A., Rudolph, K. L., & DePinho, R. A. (2003) · PubMed · Cited by 201
Self-citationGenetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
Wong, C., Lee, J. M., Ching, Y.-P., Jin, D., & Ng, I. O. (2003) · PubMed · Cited by 198
Aurora kinases: shining lights on the therapeutic horizon?
Andrews, P. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208752 · Cited by 180
Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells
Daniel, D., Meyer-Morse, N., Bergsland, E. K., Dehne, K., Coussens, L. M., & Hanahan, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021047 · Cited by 180
High frequency of p16INK4A gene alterations in hepatocellular carcinoma
Liew, C. T., Li, H.-M., Lo, K.-W., Leow, C. K., Chan, J. Y., Hin, L. Y., Lau, W. Y., Lai, P. B. S., Lim, B. K., Huang, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202359 · Cited by 180
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J. W., & Oshimura, M. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00329-9 · Cited by 174 · cited 1×
“Telomere shortening has been described as a key feature of chronic hyperproliferative liver diseas”
BackgroundHöpfner, M., Sutter, A. P., Huether, A., Schuppan, D., Zeitz, M., & Scherübl, H. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.024 · Cited by 173
Mechanisms leading to chromosomal instability
Gollin, S. M. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.09.004 · Cited by 164
Macdonald, A., Crowder, K., Street, A., McCormick, C., Saksela, K., & Harris, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210900200 · Cited by 161
Sakata, H., Takayama, H., Sharp, R., Rubin, J. S., Merlino, G. T., & LaRochelle, W. J. (1996) · PubMed · Cited by 153
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 151
Telomere Shortening in Chronic Liver Diseases
Kitada, T., Seki, S., Kawakita, N., Kuroki, T., & Monna, T. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1774 · Cited by 148
Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
Smith, M. W., Yue, Z. N., Geiss, G. K., Sadovnikova, N. Y., Carter, V. S., Boix, L., Lázaro, C. A., Rosenberg, G. B., Bumgarner, R. E., Fausto, N., et al. (2003) · PubMed · Cited by 148
Liver Transplantation for Malignancy
Hertl, M., & Cosimi, A. B. (2005) · The Oncologist · doi:10.1634/theoncologist.10-4-269 · Cited by 139
Sandgren, E. P., Luetteke, N., Qiu, T. H., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.320-330.1993 · Cited by 135
Daveau, M., Scotté, M., François, A., Coulouarn, C., Ros, G., Tallet, Y., Hiron, M., Hellot, M., & Salier, J. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10103 · Cited by 131
Plentz, R. R., Caselitz, M., Bleck, J. S., Gebel, M., Flemming, P., Kubicka, S., Manns, M. P., & Rudolph, K. L. (2004) · Hepatology · doi:10.1002/hep.20271 · Cited by 131
The Liver: Biology and Pathobiology
Iber, F. L. (2002) · JAMA · doi:10.1001/jama.287.4.524 · Cited by 128
Webber, E. M., Wu, J. C., Wang, L., Merlino, G. T., & Fausto, N. (1994) · PubMed Central · Cited by 123
Santoni‐Rugiu, E., Nagy, P., Jensen, M. R., Factor, V. M., & Thorgeirsson, S. S. (1996) · Europe PMC (PubMed Central) · Cited by 120
Monocyte activation in alcoholic liver disease
McClain, C. J., Hill, D. B., Song, Z., Deaciuc, I. V., & Barve, S. S. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00212-4 · Cited by 120
Huang, S.-N., & Chisari, F. V. (1995) · Hepatology · doi:10.1002/hep.1840210303 · Cited by 119
Farazi, P. A., Glickman, J. N., Horner, J. W., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Self-citationYu, C. R., Hsu, J.-M., Lee, Y.-C. G., Tsou, A., Chou, C., & Huang, C. F. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5789-5800.2005 · Cited by 118
Majumder, M., Ghosh, A. K., Steele, R., Zhou, X., Phillips, N. J., Ray, R., & Ray, R. B. (2002) · Virology · doi:10.1006/viro.2001.1309 · Cited by 114
Prange, W., Breuhahn, K., Fischer, F. F., Zilkens, C., Pietsch, T., Petmecky, K., Eilers, R., Dienes, H., & Schirmacher, P. (2003) · The Journal of Pathology · doi:10.1002/path.1448 · Cited by 112
Kanai, Y., Hui, A., Sun, L., Ushijima, S., Sakamoto, M., Tsuda, H., & Hirohashi, S. (1999) · Hepatology · doi:10.1002/hep.510290338 · Cited by 111
Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., & Hirohashi, S. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00316-x · Cited by 108
A Comprehensive Karyotypic Study on Human Hepatocellular Carcinoma by Spectral Karyotyping
Wong, N., Lai, P. B. S., Pang, E., Leung, T. W., Lau, J. W. Y., & Johnson, P. J. (2000) · Hepatology · doi:10.1053/jhep.2000.19349 · Cited by 103
Braun, L., Mikumo, R., & Fausto, N. (1989) · PubMed · Cited by 102
Jian, Y. U., Zhang, H. Y., Zhong, Z., Lu, W., Wang, Y., & Jingde, Z. H. U. (2003) · Cell Research · doi:10.1038/sj.cr.7290177 · Cited by 102
橋本, 毅., Mori, N., Tamesa, T., Okada, T., Kawauchi, S., Oga, A., Furuya, T., Tangoku, A., Oka, M., & Sasaki, K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800107 · Cited by 101
Calvisi, D. F., Factor, V. M., Ladu, S., Conner, E. A., & Thorgeirsson, S. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.014 · Cited by 100
Vitronectin induces migration of activated T lymphocytes
Edwards, S., Price, K. H., & Adams, D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)81190-3 · Cited by 100
Wilkens, L., Flemming, P., Gebel, M., Bleck, J. S., Terkamp, C., Wingen, L. U., Kreipe, H. H., & Schlegelberger, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305817101 · Cited by 97
Tarn, C., Lee, S., Hu, Y., Ashendel, C. L., & ANDRISANI, O. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104105200 · Cited by 97
Okabe, H., Ikai, I., Matsuo, K., Satoh, S., Momoi, H., Kamikawa, T., Katsura, N., Nishitai, R., Takeyama, O., Fukumoto, M., et al. (2000) · Hepatology · doi:10.1053/he.2000.6409 · Cited by 96
Cellular origin of hepatocellular carcinomas
Sell, S. (2002) · Seminars in Cell and Developmental Biology · doi:10.1016/s1084952102001295 · Cited by 94
Ishizaki, Y., Ikeda, S., Fujimori, M., Shimizu, Y., Kurihara, T., Itamoto, T., Kikuchi, A., Okajima, M., & Asahara, T. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.5.1077 · Cited by 93
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?
Pachiadakis, I., Pollara, G., Chain, B., & Naoumov, N. V. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70114-6 · Cited by 93
Telomere length in human liver diseases
Urabe, Y., Nouso, K., Higashi, T., Nakatsukasa, H., Hino, N., Ashida, K., Kinugasa, N., Yoshida, K., Uematsu, S., & Tsuji, T. (1996) · Liver · doi:10.1111/j.1600-0676.1996.tb00748.x · Cited by 87
Marrogi, A. J., Ma, K., van Gijssel, H. E., Welsh, J. A., Rahim, H., Demetris, A. J., Kowdley, K. V., Hussain, S. P., Nair, J. R., Bartsch, H., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1652 · Cited by 85
Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis
Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., Sugimura, T., & Hirohashi, S. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03135.x · Cited by 83
Park, K.-J., Choi, S., Choi, D., Park, J.-M., Yie, S. W., Lee, S. Y., & Hwang, S. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209623200 · Cited by 82
Ghebranious, N., & Sell, S. (1998) · Hepatology · doi:10.1002/hep.510270211 · Cited by 81
Sandgren, E. P., Luetteke, N., Qiu, T. H., et al. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.320 · Cited by 79
Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas
竹尾, さ., Arai, H., Kusano, N., Harada, T., Furuya, T., Kawauchi, S., Oga, A., Hirano, T., Yoshida, T., Okita, K., et al. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00479-4 · Cited by 78
Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis
Oh, B.-K., Chae, K. J., Park, C., Kim, K. S., Lee, W. J., Han, K., & Park, Y. N. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00395-7 · Cited by 77
Nijhara, R., Jana, S. S., Goswami, S. K., Rana, A., Majumdar, S. S., Kumar, V., & Sarkar, D. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10348-10358.2001 · Cited by 77
Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma
Saeki, A., Tamura, S., Ito, N., Kiso, S., Matsuda, Y., Yabuuchi, I., Kawata, S., & Matsuzawa, Y. (2002) · Cancer · doi:10.1002/cncr.10448 · Cited by 73
Limdi, J. K., & Crampton, J. R. (2004) · QJM · doi:10.1093/qjmed/hch065 · Cited by 73
Kawai, H., Suda, T., Aoyagi, Y., Isokawa, O., Mita, Y., Waguri, N., Kuroiwa, T., Igarashi, M., Tsukada, K., Mori, S., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.7298 · Cited by 71
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Murata, H., Tsuji, S., Tsujii, M., Sakaguchi, Y., Fu, H. Y., Kawano, S., & Hori, M. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700118 · Cited by 70
Plentz, R. R., Schlegelberger, B., Flemming, P., Gebel, M., Kreipe, H. H., Manns, M. P., Rudolph, K. L., & Wilkens, L. (2005) · Hepatology · doi:10.1002/hep.20847 · Cited by 70
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
Tyrosine and its catabolites: from disease to cancer.
Tanguay, R. M., Jorquera, R., Poudrier, J., & St‐Louis, M. (1996) · Acta Biochimica Polonica · doi:10.18388/abp.1996_4530 · Cited by 66
Telomerase activity in precancerous hepatic nodules
Hytiroglou, P., Kotoula, V., Thung, S. N., Tsokos, M., Fiel, M. I., & Papadimitriou, C. S. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10<1831::aid-cncr4>3.0.co;2-q · Cited by 63
Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma
Nagao, K., Tomimatsu, M., Endo, H., Hisatomi, H., & Hikiji, K. (1999) · Journal of Gastroenterology · doi:10.1007/s005350050220 · Cited by 60
Ghebranious, N., & Sell, S. (1998) · Hepatology · doi:10.1002/hep.510270411 · Cited by 58
Genetic Profiling of Human Hepatocellular Carcinoma
Lee, J., & Thorgeirsson, S. S. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871192 · Cited by 57
Sargent, L. M., Zhou, X., Keck, C. L., Sanderson, N. D., Zimonjic, D. B., Popescu, N. C., & Thorgeirsson, S. S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65357-6 · Cited by 56
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Koo, S. H., Ihm, C. H., Kwon, K. C., Park, J. W., Kim, J., & Kong, G. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00460-5 · Cited by 54
Comporti, M., Arezzini, B., Signorini, C., Sgherri, C., Monaco, B., & Gardi, C. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700332 · Cited by 53
Functional evidence for a telomerase repressor gene on human chromosome 10p15.1
Nishimoto, A., Miura, N., Horikawa, I., Kugoh, H., Murakami, Y., Hirohashi, S., Kawasaki, H., Gazdar, A. F., Shay, J. W., Barrett, J. C., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204165 · Cited by 53
Ethanol Metabolism Alters Interferon Gamma Signaling in Recombinant HepG2 Cells *
Osna, N. A., Clemens, D. L., & Donohue, T. M. (2005) · Hepatology · doi:10.1002/hep.20909 · Cited by 52
Comparative functional genomics for identifying models of human cancer
Lee, J., Grisham, J. W., & Thorgeirsson, S. S. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi030 · Cited by 52
Kobayashi, T., Kubota, K., Takayama, T., & Makuuchi, M. (2001) · The American Journal of Surgery · doi:10.1016/s0002-9610(01)00566-9 · Cited by 44
Mutation of p53 gene in regenerative nodules in cirrhotic liver
Minouchi, K., Kaneko, S., & KOBAYASHI, K. P. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00144-7 · Cited by 37
In situdetection of telomerase enzymatic activity in human hepatocellular carcinogenesis
Youssef, N., Paradis, V., Ferlicot, S., & Bédossa, P. (2001) · The Journal of Pathology · doi:10.1002/path.901 · Cited by 37
Grant, L. (2004) · QJM · doi:10.1093/oxfordjournals.qjmed.a005114 · Cited by 36
Progenitor cell activation in chronic viralhepatitis
Fotiadu, A., Tzioufa, V., Vrettou, E., Koufogiannis, D., Papadimitriou, C. S., & Hytiroglou, P. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00908.x · Cited by 36
Shimojima, M. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.02.005 · Cited by 33
Kubo, T., Yamamoto, J., Shikauchi, Y., Niwa, Y., Matsubara, K., & Yoshikawa, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3314 · Cited by 30
Nijhara, R., Jana, S. S., Goswami, S. K., Kumar, V., & Sarkar, D. P. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02773-9 · Cited by 25
Hwang, H.-J., Kim, G. J., Lee, G.-B., Oh, J.-T., Chun, Y.-H., & Park, S.-H. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00671-4 · Cited by 16
Expression of the Hoxa-13 Gene Correlates to Hepatitis B and C Virus Associated HCC
Huang, T., Chesnokov, V., Yokoyama, K. K., Carr, B. I., & Itakura, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4470 · Cited by 15
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma
Piao, Y., He, M., Shi, Y., & Tang, T.-Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i14.2147 · Cited by 11
Phenotype modulation of human adult fibroblasts by oncogenes
Kopelovich, L., & Demian, S. E. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199603)15:3<183::aid-mc4>3.0.co;2-j · Cited by 3
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Metadata
- Authors
- Farazi, P. A., & DePinho, R. A.
- Venue
- Nature Reviews Cancer
- Published
- 2006-09-01
- Volume
- 6
- Issue
- 9
- Pages
- 674-687
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2088629624
- Cited by
- 1,979
- References
- 161
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.